B. Metzler seel. Sohn & Co’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
B. Metzler seel. Sohn & Co's RMD Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co held its ResMed (RMD) position steady in Q1 2026 at 10,259 shares worth $2.3M. The position accounts for 0.02% of the portfolio, ranked #360.
B. Metzler seel. Sohn & Co first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $16.4M in Q2 2023. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- B. Metzler seel. Sohn & Co held 10,259 shares of ResMed worth $2.3M as of Q1 2026.
- B. Metzler seel. Sohn & Co left its ResMed share count unchanged in Q1 2026.
- ResMed made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #360 holding.
- B. Metzler seel. Sohn & Co first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
- B. Metzler seel. Sohn & Co's ResMed position peaked at $16.4M in Q2 2023.
- 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.